samedan logo

 
 
spacer
home > ebr > Spring 2022
PUBLICATIONS

European Biopharmaceutical Review

ebr
Spring 2022

   
Text
PDF
   

spacer


Published quarterly in
January, April,
July, and October

News and Press Releases

AffyXell Expands its Strategic Partnership with GenScript ProBio

London and Wetherby, UK, 16 May 2022: Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company developing innovative cancer therapies and powerful diagnostics based on its proprietary pre|CISION™ and Affimer® platforms, is pleased to announce that AffyXell, its joint venture with South Korean drug maker Daewoong Pharmaceutical, has expanded its strategic partnership with GenScript ProBio, a leading biopharmaceutical manufacturer.
More info >>

White Papers

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement